Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: A dose-finding study

1. Esteban, E.
2. Modollel, A.
3. De Sande, L.G.
4. Palacio, I.
5. Muñiz, I.
6. Fernández, Y.
7. Corral, N.
8. Fra, J.
9. Sala, M.
10. Vieitez, J.M.
11. Estrada, E.
12. Lacave, A.J.